These innovative medications , including copyright , belong to a group of drugs called GLP-1 agents. Originally intended for controlling type 2 diabetes , they operate by helping the body to produce adequate the hormone insulin and reducing high sugar levels. Furthermore , their ability to promote slimming has contributed to increased discussion he